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Abstract
Background: Pharmaceutical uterotonics are effective for preventing postpartum hemorrhage and complications
related to unsafe abortion. In Madagascar, however, traditional birth attendants (Matrones) commonly administer
medicinal teas for uterotonic purposes. Little is known about Matrone practices and how they might coincide with
efforts to increase uterotonic coverage. The aims of this study were to: 1) identify indications for presumed
uterotonic plant use by Matrones, 2) explore uterotonic practices at the village level, and 3) describe the response
of health practitioners to village-level uterotonic practices.
Methods: Twelve in-depth interviews with health practitioners, Matrones and community agents were conducted
in local dialect. All interviews were audio-recorded, transcribed, and translated into English for analysis using Atlas.ti.
Medicinal plant specimens were also collected and analyzed for the presence of uterotonic peptides.
Results: While Matrones reported to offer specific teas for uterotonic purposes, health practitioners discussed
providing emergency care for women with complications associated with use of specific teas. Complications
included retained placenta, hypertonic uterus, hemorrhage and sepsis. Chemical analysis indicated the presence of
cysteine-rich peptides in the Dantoroa/Denturus plant used in some Matrones’ teas.
Conclusions: The presence of uterotonic peptides in one plant used by Matrones may indicate that Matrones
intend to administer uterotonics for safer childbirth. This finding, combined with practitioner reports of
complications related to some medicinal teas, points to a need for availability of an evidence-based uterotonic at
the village level, namely, misoprostol pills or oxytocin in the form of uniject.
Keywords: Uterotonic, Postpartum hemorrhage, Misoprostol, Traditional medicine, Matrones, Cyclotides,
Dantoroa/Denturus
Background
Each year, roughly 300,000 women die as a result of
pregnancy or childbirth related complications; 99 % of
these deaths occur in developing countries [1, 2].
Postpartum hemorrhage (PPH) and unsafe abortion
together contribute to almost half of these deaths [3, 4].
Although pharmaceutical uterotonics are effective at
preventing deaths from both of these indications, they
are simply not accessible for most who give birth in
rural, low-resourced areas each year without a skilled
birth attendant.
Madagascar has a high maternal mortality ratio,
estimated at between 297 and 400 deaths for every
100,000 live births [2, 5]. Of these, 39 % are attributable
to PPH [6]. Unsafe abortion also poses a threat to mater-
nal health, as an estimated 25 % of Malagasy women
have terminated a pregnancy without access to safe
abortion care [7]. Due to legal restrictions, however, the
impact of unsafe abortion is not fully recognized.
Uterotonic coverage is low in Madagascar for several
reasons. Although national policy requires uterotonic
administration at health facility deliveries in the form of
injectable oxytocin (10 IU IV/IM) or, less commonly,
ergometrine, stock-outs and power outages complicate
the extent of coverage at these births. A 2011 Maternal
and Child Health Integrated Program (MCHIP) report
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on quality of care in facilities across the 22 regions of
Madagascar found that 65 % of facilities reported having
the drugs, supplies, and equipment to deliver an inject-
able uterotonic [8]. However, only 35 % of Malagasy
women actually deliver in a health facility; a percentage
that drops significantly in rural areas [9].
The most common uterotonic currently used outside
of the facility setting is oral misoprostol (600 μg), which
is a slightly less effective yet heat-secure tablet-form
uterotonic that can be self-administered or overseen by
an unskilled attendant [10, 11]. Misoprostol is not
currently registered as a generic medicine for PPH
prevention in Madagascar. It is currently only available
at Marie Stopes clinics under the name Misoclear. The
argument for local registration of misoprostol as a
generic medicine for reproductive health is supported by
evidence from 1) a clinical trial in Antananarivo that
showed efficacy and acceptability of the drug among
women treated for incomplete abortions, and 2) a recent
project by USAID’s MCHIP in Madagascar, which exam-
ined the feasibility of increasing uterotonic coverage
through community distribution of misoprostol to pre-
vent PPH at home births [12]. Registration of this drug
for reproductive health purposes is controversial in
Madagascar, given concerns that misoprostol availability
might increase incidence of abortions if misused, or
uterine rupture if taken before the third stage of labor.
Most Malagasy women in rural areas seek reproduct-
ive health care outside of health facilities with untrained
traditional birth attendants known as Matrones. Little is
understood, however, about the practices and medicines
used by Matrones during childbirth or other consulta-
tions. Anecdotal evidence suggests some Matrones may
commonly provide women with a tambavy, or medicinal
tea, to drink during or after delivery. It is believed that
the medicinal plants used in certain teas have uterotonic
effects, but little is understood specifically regarding the
uterotonic effects among the plants utilized in these teas.
Such effects have been documented among herbal rem-
edies available elsewhere [13]. Cyclotides (small peptides
rich in disulfide bonds with numerous biological actions,
including uterotonic activity) were originally discovered
from the coffee family plant Oldenlandia affinis DC.
(Rubiaceae) due to its use in traditional medicine in the
Democratic Republic of Congo to accelerate childbirth by
uterine stimulation [14]. Recently the pharmacological
properties of this medicinal plant have been studied and it
has become evident that cyclotides modulate the oxytocin
receptor to induce uterine contractions [15].
This paper aims to inform community-based utero-
tonic campaigns in Madagascar by providing insight on
the context into which such a program might infiltrate:
home births attended by Matrones. Through an ethno-
botanical lens, this paper describes uterotonic practices
at the village level and the responses of health practi-
tioners providing care to women after ingestion of
presumed uterotonic teas during childbirth. The chem-




Fenerive-Est district is located in Analanjirofo Region
(the region of cloves) on the northeastern coast of
Madagascar, where an estimated 83.5 % of residents live
in impoverished conditions [16]. The district consists of
12 communes and 149 villages, yielding a total popula-
tion of 362,549 residents, most of whom rely on rice
farming and clove harvesting for household income [16].
Access to health care is limited, and each of the district’s
26 public health centers, known as Centre de Santé de
Base (CSB), is generally staffed by only one doctor and/
or one midwife. There is one district hospital, located in
Fenerive-Ville. Like other rural regions of Madagascar,
Fenerive-Est has a volunteer Community Agent (CA) pro-
gram through which community members are trained to
provide sensitization on certain health topics related to
child and maternal health. There are 211 CAs (desig-
nated as CA Child or CA Mother), supervised by health
providers in the district.
Fenerive-Est was a favorable choice for this study
because it was the site of the MCHIP Madagascar PPH
prevention project, which piloted community-based dis-
tribution of misoprostol through CAs for use during
home births. The CAs in this region were familiar with
the project and were willing to offer additional support
for this follow-up study on the local use of uterotonic
tambavy in the study site. Specifically, the CAs helped
recruit known Matrones in the villages to be in-
terviewed. Throughout Madagascar, Matrones are not
legally permitted to attend births; however, in rural areas
each village has at least one Matrone, and most women
visit a Matrone before seeking care at the CSB. Only
13 % of women in Fenerive-Est deliver in a facility,
meaning that the majority of pregnant women are de-
livering without skilled attendance, most often with a
Matrone [16].
Selection of sample and recruitment of participants
Participants were recruited through stratified purposeful
sampling of health providers including doctors, midwives,
CAs and Matrones in selected villages of Fenerive-Est
district. These sources were assumed to have the most
knowledge in the study region about medicinal plant use
for reproductive health purposes. Source triangulation
was employed to obtain multiple perspectives on the
topics under investigation. Villages were chosen based on
the presence of a CA participating in the MCHIP
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misoprostol distribution project. Physicians and Matrones
were sought out who served the catchment populations of
these villages. For logistical purposes, villages were se-
lected close to Fenerive-Ville; village-level respondents
lived within a 20-kilometer proximity to the district
hospital. As physicians are scarce in the region, one
midwife and two doctors interviewed practiced outside of
Fenerive-Ville.
For each village that was selected, CAs were typically
the first point of contact for the researcher and inter-
preter. CAs either introduced the researchers to the
Village Chief, who then recruited the Matrone to be
interviewed, or if the Village Chief was unavailable, the
CA then went directly to the known Matrone for
recruitment. Of the 7 Matrones identified, 5 agreed to
participate. One of the Matrones was not at home, and
another stated that since she was very old she no longer
could speak of the spiritual work of her hands. All of the
village-level interviewees were female; one male trad-
itional healer was approached but not available for inter-
view at that time.
At the facility level, recruitment of doctors and mid-
wives working in the study region was facilitated by
contacts in the MCHIP program. The interviewer met
each participant in a private location of the interviewee’s
choosing to conduct the interview. Three of the health
practitioner interviews took place in Antananarivo be-
cause two doctors and one midwife happened to be in
the capital at the time of the study, either for training or
other work. Health providers included 2 male doctors, 1
female doctor, and two female midwives.
A sample size of 12 for in-depth interviews is within
standard qualitative research guidelines considering the
research question of interest, the specific geographic
region, and the size of the sample pool from which we
drew our sample [17].
Measures/Topics of interest
The primary aim of this study was to collect information
on the indications for use of presumed uterotonic tamba-
vys, uterotonic practices at the village level, and health prac-
titioners’ responses to local uterotonic practices. Separate
interview guides were used during interviews with village-
level participants and health providers. All interviews aimed
at obtaining information about uterotonic practices at the
village-level. Interviews with health facility providers also
aimed to identify the extent and source of practitioner
knowledge about tambavys, and whether they knew of or
had witnessed any complications related to traditional
uterotonic practices. The village-level interview tool was
pre-tested by field staff with CAs in the study site. Do-
mains, sample questions and probes from both in-depth-
interview guides are included in Table 1. Interviews were
conducted by a student researcher and trained interpreter.
Interview data analysis
All translated transcripts were uploaded into Atlas.ti
(version 7) for coding and analysis. Using an inductive
content analysis approach, in which the transcripts are
first read to identify the primary themes that were emer-
ging, an initial set of codes was developed that mapped
onto the primary themes [18]. After the initial set of codes
was created, transcripts were re-read and analytical sub-
codes were created that further defined the coding struc-
ture. Coding continued until all data was assigned to a code
and saturation was achieved [19]. To compare the codes
across groups, matrices of the key codes were created. For
the present analysis, these related to indications for utero-
tonic tambavy use and the response of physicians.
A number of techniques were used to ensure that the
data collected and analyzed was trustworthy [20]. First,
data collection instruments were translated from English
into Malagasy by the project interpreter, then quality-
checked by a professional translator from the MCHIP
Madagascar office. Additionally, to ensure participant
confidentiality and ease in sharing sensitive topics, such
as childbirth and abortion, we provided informed con-
sent orally and made sure the participant selected the
location and time for the interview. Furthermore, given
that no new information was being obtained after our
10th interview conducted, we knew that 12 interviews
were sufficient to achieve saturation. During our analysis
phase, we also performed a number of checks to ensure
trustworthiness of our interpretations and conclusions
of the data. First, as part of our coding process, we
continuously sought feedback from field staff about the
meaning and relevance for the code labels we created.
Additional memos of our thoughts about the interpret-
ation of our data were also created alongside our code
labels. Finally, preliminary findings were shared with the
field staff to further assist us in our interpretation and
conclusions drawn from the data. For these reasons, and
our transparent documentation of our data collection
procedures and analysis, we believe that the data and
our interpretations of the data have been adequately
assessed for quality and credibility.
Plant specimen and chemical analysis
Medicinal plant specimens were gathered alongside
qualitative data. These plants were either given to the
researcher or purchased from the Matrones following
the interview as examples of plants used during
childbirth for accelerating delivery and to stop bleed-
ing. These plant samples were Amborabe, Atafana,
Antamba and Dantoroa/Denturus. Following the com-
pletion of data collection, the samples were refriger-
ated in plastic bags before shipment. In the laboratory,
these plant samples were extracted overnight and the
aqueous methanol fraction was further treated by C18
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Table 1 Domains of interest and sample questions with probes for semi-structured interviews with Doctors, Midwives, Matrones, and Community Agents in Fenerive-Est District
Domains Grand-tour question Care-seeking behaviors Matrone Practices Medicinal Plant Use Interactions and relationship
between formal and
informal providers
Questions I'd like to start by asking for your
opinion on the current state of
reproductive health in this area.
I do not know what reproductive
health services are available in this
area, like from doctors and matrones.
Could you tell me about this?
In your opinion, what may
influence people to seek
reproductive health care
from traditional village level
providers or doctors or
midwives at the CSB?
From what you know of the
people of the village, for what
reason do they come to a
Matrone for reproductive health
care and for what reason do
they come to doctors or
midwives for reproductive
health care?
Can you tell me what you know
about medicinal plants and how
they are used in this region?
Is there something that you believe
would improve reproductive health
in your area? Is there a service that
needs to be improved or anything
that you suggest that would
help women?
I have heard about a plant found in
this region that may have uterotonic
properties. It may be used as a
traditional medicine in the same
way that a uterotonic would be
used – administered to induce
uterine contractions. Can you tell
me about that?
Do you believe that it is possible
for the formal and informal sectors
to work together to improve the
health of women?
Probes Please describe clientele who
seek your reproductive health
services – age groups, social
classes, marital status, etc.
How are the services received
at the village-level and at the
CSB the same or different?
Do they visit a matrone many
times or just one time before
going to the CSB?
Walk me through the process- step
by step. What is done to gather and
prepare the plant? Once the plant has
been prepared, what is the first step
for using it? Then what must happen?
Please tell me the entire process from
when the woman is given the plant
until it is finished and the woman
has recovered.
If a woman experiences complications
like you mentioned, will she be able
to reach the hospital? How does she
get there?
In your opinion, are these services
enough to meet the needs of
people in this area?
Can you tell me what factors
would be influencing people
to seek reproductive health
services from a Matrone or
traditional healer rather than
at the CSB?
How does a matrone know if
she can do it (assist the woman
in delivery) or if she can't?
Can women afford the cost of care
in the hospital?
What is the difference between the
care provided at the doctor/midwife
versus the care provided by matrones?
What do people do here to
promote reproductive health?
Do people seek matrones
for other reproductive
health services?
Do you think that the plants work as
the traditional providers and women
intend them to?
How do you think women are
treated when they go to the
hospital?
Can you tell me about the
acceptability of family planning
here? What methods do people
use, if any?
Do all Matrones provide
the same services?
Have you ever heard of women
having problems during or after
using this plant? What problems
might she have?
Are there barriers to collaboration
between the formal and informal
health providers?
If a woman becomes pregnant
and she did not intend to, what
can she do?















solid-phase extraction. The samples were analyzed by
combination of solvent extraction, chemical derivati-
zation and matrix-assisted laser desorption ionization
time-of-flight (MALDI-TOF) mass spectrometry for
presence of uterotonic cyclotides [15]. The plant sam-
ples were treated and analyzed according to previously
published protocols [21, 22].
Ethical considerations
Only one point of contact was made with participants
during data collection, and no personal information was
collected from study participants to protect their priv-
acy. Oral consent was obtained in the participant’s native
language prior to the interview. To maintain participant
confidentiality, pseudonyms are used in place of partici-
pant names in the results that follow. The interviews
were constructed to obtain participant knowledge rather
than personal histories. Thus, this study was declared
not human subjects research and received exempt status
from the Johns Hopkins Bloomberg School of Public
Health Institutional Review Board. The Madagascar Eth-
ics Committee in Antananarivo granted study approval




Matrones reported routinely providing women with a
tambavy (medicinal tea); uses included washing the
womb, regulating fertility, or accelerating delivery and
treating complications such as retained placenta or post-
partum hemorrhage. Matrones appeared comfortable
discussing the applications of plants in their work. As
one explained:
It depends on the sickness; maybe the woman is
bleeding too often, or maybe she has a problem in
her womb. Then, there are appropriate plants to
be boiled and drunk as tea. (Nala, Matrone)
Matrones stated that they have to go far into the forest
to gather medicinal plants, or, if that is not possible, they
purchase them from others. Plants are not always avail-
able, which affects the Matrones’ work. A complete list
of plants and tambavys according to reproductive health
purpose, as mentioned by interviewees, is provided in
Tables 2, 3 and 4.
Indications for uterotonic tambavy use and the response
of physicians
Tambavys as abortifacients
When asked about knowledge of tambavys used as abor-
tifacients, Matrones insisted that they do not know
because they themselves do not do abortions. However,
several Matrones, doctors, midwives, and CAs refer-
enced plants used for abortion or post-abortion care
during their interviews (see Tables 2, 3 and 4). Although
no health practitioners mentioned tambavys used as
abortifacients, two doctors referenced specific plant
stems (from the Nifin’akanga and Ahilava plants) used to
induce abortion, for which they have encountered
patients with complications including sepsis and per-
forated uterus. One Matrone said that she knew what
plants could be boiled in a tea to terminate pregnancy,
but would not tell more, citing the danger:
I do not dare show people about it because it is
delicate. It is delicate because there is a dosage to
respect. If it is too much, it may bring about
hemorrhage. That is why I do not attend an abortion,
neither do I show people how to do it. (Anja, Matrone)
The Matrones interviewed said that abortion brings
misfortune; yet all acknowledged that abortion was
performed by both health practitioners and traditional
healers in the area despite awareness of associated dan-
gers. One doctor and one midwife refused to discuss
abortion, citing that they know nothing about it. Another
doctor noted:
Table 2 Medicinal Plants Used for Reproductive Health Purposes, as Identified by Interviewees
Medicinal Plants Used During Delivery
To Aide in Delivery/Accelerate Delivery To Treat Retained Placenta/Deliver Placenta To Treat Postpartum Hemorrhage












(Matrones, Community Agents, and Health Providers in Fenerive-Est, Madagascar)
aIndicates plant specimens that were assessed for the presence of putative cyclotides
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When I was in the maternity [hospital], in one day
you could have three cases of complications from
abortion and from using these plants for other
methods. (Julien, Doctor)
Village-level respondents regarded abortion to be
dangerous but common, especially among youth. These
interviewees stated that their response to abortion was
to refer the woman to a hospital or drive her away. One
Matrone said:
When a woman comes to me after an abortion, I
always know. I first ask her "did you commit
abortion?" She says, "Yes." And I ask her who did
it, a Malagasy or a foreigner. If she says that a
Malagasy did it, I tell her to go back there for a
cure because it can "harm" my hands. That is to
say, it can bring misfortune to my hands. It "hurts"
my hands and people won't come to me anymore.
(Rinà, Matrone)
Tambavy use during labor
Indications for medicinal plant use during labor, as
recounted by Matrones, include: to accelerate labor, to
“aide” in delivery, to deliver the placenta, and to prevent
and treat hemorrhage. All respondents agreed that
uterotonic plants appear to work as intended, although
Matrones were more likely to state that there are no side
effects related to tambavy use, while health practitioners
referenced potential complications including retained
placenta, hypertonic uterus, hemorrhage and sepsis. One
midwife explained:
Some women come [to a health facility] due to
hemorrhage because the contractions are too fast and
bring about the tear of the cervix… the contraction
provokes hypertony of the uterus…[Women] only have
access to that plant at the matrone. Only the matrone
knows how to use it. It probably works because the
uterus is contracting strongly indeed. It works like
oxytocin. (Aina, Midwife)
The midwife continued to recount her experience with
a woman suffering from retained placenta, which she
stated was caused by a tambavy provided by a Matrone.
The tambavy mentioned below, called Fankamora, was
the only potentially uterotonic tea specifically identified
by practitioners as causing complications:
I do not know what the plant is but some women who
come here after being to the matrone suffer of placenta
retention. Those women are given a tea by the
matrone called Fankamora that quickens the delivery.
When the woman drinks that tea, contractions are
more intense and the baby is delivered but just after
that, the cervix contracts and the placenta is trapped.
Then the woman is sent to hospital and we have to
relax the cervix to free the placenta… It is totally
closed. You can just see the umbilical cord. And then,
we ask them to buy some antispasmodics to relax the
spasms. Antispasmodics are used to relax the muscles
and once it is relaxed, the placenta is delivered. I do
not know the name of the plant but I just know that
the tea is called Fankamora…It is quite frequent
(Aina, Midwife).
Dosage
Of primary concern is dosage of plant administration, a
theme that emerged in interviews with both Matrones
and health practitioners. One doctor said:
We do not know what the side effects might be. The
problem is that the matrone does not even know about
the right dosage, what may happen if it is too much…
For example, she may tell the woman to boil a
Table 3 Medicinal Plants Used for Reproductive Health Purposes, as Identified by Interviewees
Medicinal Plants Used in Fertility Regulation
For Family Planning As Abortifacient To Wash the Womb Medicinal plants Used for Post Abortion Care
Flo Leaf & Tsimangarato Ahilava (Stem) Nokoehy Fandava Tsidihika followed by Tanantrandraka
Avocado Leaf Rainmandaly
Nifin’akanga (Stem) Tanantrandraka
Romba (with Cytotec) Vahazo
Vatolalaka Vanilla (with a “tasteless” tea)
Velonahantona
Table 4 Medicinal Plants Used for Reproductive Health
Purposes, as Identified by Interviewees
Medicinal Plants that Health Providers Associate with Complications
Fankamora: Nifin’akanga/Ahilava (Stems):
Rapid Contractions Sepsis Infection
Hypertonia Perforated Uterus
Hemorrhage from Cervical Tear
(Matrones, Community Agents, and Health Providers in
Fenerive-Est, Madagascar)
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handful of the plant but the problem is that a
handful for the matrone might be different from the
handful of the woman. So, there might be a risk of
overdose and I am sure that it provokes [retained
placenta] (Nadie, Doctor).
Doctors and midwives expressed concern of potential
dangers if these plants are used in addition to the admi-
nistration of a pharmaceutical uterotonic. One Matrone
mentioned giving women misoprostol if the uterotonic
tambavy administered does not stop PPH. To avoid
complications such as hypertonic uterus, ruptured uterus
or retained placenta, which participants stated could occur
in the event of uterotonic overdose, health providers don’t
allow a woman’s family to give her anything to drink
during labor. Doctors and midwives said that they ask the
woman what she ate or drank before arriving at the
facility; many times the woman does not want to tell.
Fear of being scolded by a health provider for seeking
traditional care was noted in interviews with Matrones.
One midwife described how care for such a patient
may proceed:
During labor, the matrone does everything to help the
woman in delivery. She gives her a tea, she asks her to
push, she tries everything according to her knowledge.
So when she gives the uterotonic tea to the woman, the
treatment varies from two to six hours. So, when it is
still difficult, the matrone sends the woman to the
hospital, and she arrives there at the fourth hour. We,
midwives too, have to try everything to help the
woman in her delivery so we have to use a medicine,
which is also a uterotonic. The plant plus the medicine
then provoke hypertonia and brings about more
complications (Hanitra, Midwife).
Plant analysis
Chemical analysis for the presence of cyclotides
Matrones provided samples of four plants used in medi-
cinal teas administered during childbirth: Amborabe,
Atafana, Antamba and Dantoroa/Denturus (see Tables 2,
3 and 4). Amborabe and Antamba were described as
aiding in delivery, Dantoroa/Denturus as an aide in
placental delivery, and Atafana as a medicine to stop
bleeding. As described previously, crude peptide extracts
of the specimen were analyzed using mass spectrometry
and chemical derivatization, treated by C18 solid-phase
extraction. Whereas the samples Amborabe, Atafana and
Antamba did not yield any molecular weight signals in
the mass range of 2000–4000 Da, the sample Dantoroa/
Denturus contained at least two signals with a molecular
weight [M +H]+ of 2331.6 and 2601.8, respectively. This
sample was further treated with reduction and alkylation
and both mass signals increased by 348 Da indicating
the presence of six cysteine residues in those com-
pounds, which is one characteristic feature of cyclotides.
These preliminary observations indicate the presence of
putative cyclotides in Dantoroa/Denturus, which needs
to be validated in future studies, by isolation and de novo
amino acid sequencing.
Discussion
The interviews revealed that Matrones routinely provide
women with tambavys (teas) that serve uterotonic pur-
poses. These can be administered to quicken or ease
labor, to deliver the placenta, or to prevent or treat PPH.
While it is generally agreed upon that the tambavys
serve their intended purposes, it is not unusual for
health practitioners to provide emergency care for
women presenting with serious complications after using
these plants. Related complications include retained pla-
centa, hypertonic uterus, hemorrhage and sepsis. Al-
though this was not explored in the current study, it is
worth noting that these complications may lead to an
increase in intra-partum related events for the newborn,
including birth asphyxia. Treatment for the above mater-
nal conditions requires skilled care including administra-
tion of an antispasmodic, antibiotic, i.v. drip and/or a
pharmaceutical uterotonic. The potential for uterotonic
overdose increases when the doctor or midwife is un-
familiar with the properties and doses of plants that a
woman has ingested. Chemical analysis pointed to the
presence of putative cyclotides in Dantoroa/Denturus,
indicating a potential uterotonic mechanism in the plant
that Matrones use to aide in delivery of the placenta.
These findings illustrate the context in which many
women in the developing world deliver, under the care
of a Traditional Birth Attendant, a category that includes
Matrones. As Madagascar continues to develop infra-
structure in its public health care system, it is likely that
women will continue to seek reproductive health care
from Matrones. The literature on the role of Traditional
Birth Attendants (TBAs) in maternal health interven-
tions was once dominated by widespread support of
TBA training as a risk-assessment strategy [23]. By the
late 1980s, when assessments seemed to indicate that
the global push for TBA training had failed to have an
impact on maternal mortality, program efforts quickly
moved away from not only TBAs, but away from any
community-based approach, and comprehensive obstetric
care in facilities became the primary focus [23, 24].
More recently, many are reconsidering the role that
community-level workers (TBAs including Matrones
and community-based midwives) might play [25].
Current debate centers on which interventions might
be delivered by these community-level workers and
what is the appropriate and optimal role for them in
terms of supporting the shift to facility births.
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In Madagascar, some TBAs have received rudimentary
training on clean birth practices. Such trainings have
demonstrated inconsistent evidence of impact on pre-
venting neonatal infection and puerperal fever in the
mother, and have not been shown to impact the mater-
nal mortality rate [23]. Although a focus on facility-level
comprehensive obstetric care has shown promise in
other settings, the poor health system infrastructure in
Madagascar cannot currently support the expansion of
these services. Due to restrictions that have prohibited
international donor support of the public sector between
the 2009 coup and 2014 and ongoing political strife,
such a health system overhaul is not anticipated in the
near future. In the meantime, task-shifting some services
from the facility to the community level can have an
impact on maternal mortality by ensuring access to es-
sential medicines, including pharmaceutical uterotonics.
Community-based distribution of misoprostol is an un-
complicated intervention endorsed by the World Health
Organization’s Partnership for Maternal, Newborn, and
Child Health as key for reducing maternal deaths [26].
Recent studies in Bangladesh, Pakistan, The Gambia and
Nepal have demonstrated misoprostol’s effectiveness in
reducing PPH in a variety of community-based settings
where community health workers or TBAs effectively
distributed misoprostol for use at home births [27–32]. In
Fenerive-Est, such a program should include sensitizing
Matrones to the benefits of administering misoprostol in
place of traditional medicines, and educating Matrones on
recognition of danger signs in order to improve facility
referral in case of a complicated birth. By distributing
misoprostol through Community Agents, a program can
monitor use through routine supervisory systems already
in place.
Until recently, oxytocin has been perceived to have
limited use in low-resource settings because it requires
cold-chain storage and the injection must be administered
by a skilled attendant. In 2012, a study by Stanton et al.
demonstrated the efficacy of oxytocin administration by
Community Health Officers using Uniject in Ghana [33];
simulation studies have demonstrated low wastage levels
(<10 %) if this intervention was provided to community-
level providers on a monthly basis, even without cold
storage [34]. This form of oxytocin is highly promising but
not yet available in most settings [35].
This study is limited in that it sampled from a small
region close to Fenerive-Ville, meaning that all village-
level participants lived within 20 kilometers of the
district hospital. These CAs and Matrones may have
different experiences than those who live in more
isolated regions in the district; reason might indicate
that women who live in these more isolated areas have
increased exposure to tambavy during pregnancy and labor
given their even more limited access to health services. The
plants used for uterotonic purposes may also vary by
region. This study was conducted in September, which is
the end of Malagasy winter; it is possible that other plants
are used during the spring and summer months, although
participants did not mention seasonal changes. Due to
constraints in time and resources, we could not collect and
analyze all plants mentioned by Matrones. A more thor-
ough ethnobotanical investigation is recommended.
Despite these limitations, the study findings have a
number of implications for programming, research, and
policy recommendations. At the program level, particu-
larly in community-based uterotonic distribution pro-
jects, Matrones should be included in awareness and
education campaigns about safe childbirth, which would
enable interventions to take advantage of missed oppor-
tunities for sensitization. In particular, Matrones should
be sensitized on correct usage and how to differentiate
between side effects of the medication and potentially
dangerous complications. At the same time, given that
Matrones are not legally permitted to attend births, but
rather should offer referrals to health centers, the
concerns of health practitioners need to be included in
any initiative that involves Matrones. It should be noted
that health practitioners in this study only identified
three plants used in traditional medicine that they associate
with maternal complications, and only one (Fankamora) is
typically used as a uterotonic. The stems of the other two
plants, Nifin’akanga and Ahilava, are used to induce
abortion, and are linked to sepsis infection and perforated
uterus. A uterotonic distribution program involving health
practitioners, Community Agents, and Matrones could
facilitate discussions to reduce use of Fankamora during
childbirth. Programs aiming to prevent unsafe abortion or
to provide post-abortion care would likewise benefit from
knowledge about use of Nifin’akanga and Ahilava stems
for pregnancy termination. The prevalence of unsafe
abortion, as reported by study participants, indicates
the need for improved or expanded family planning
programs, including a spectrum of methods available
at the village level.
In addition to these program-level implications, the
study findings also present opportunities for further
research. In this context, it is necessary to determine
how misoprostol may replace uterotonic tambavys at
home births while further research is done to identify if
the tambavys indeed have uterotonic properties. There
is a growing body of literature to support these efforts
[36, 37]. In 2012, Tripathi et al. published a structured
review of literature on traditional uterotonics used in
Sub-Saharan Africa. This study found that 208 plants
had been documented for their uterotonic applications,
and of these, 82 plant species had been confirmed to
have uterotonic activity through pharmacologic evalu-
ation [38]. Analysis of plants collected during this study
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did not confirm or deny uterotonic properties; further
research is encouraged to determine the efficacy of these
plants and to identify interventions to address plant use
during labor.
Although study findings provide some insight to
village-level uterotonic practices, they are not sufficient
to inform the actions of health practitioners who re-
spond to women presenting with complications after
plant use. These providers should have knowledge of the
traditional uterotonic practices in their region, be able to
recognize side effects and complications of plant use,
and provide appropriate treatment if traditional and
pharmaceutical uterotonic agents are combined [11].
While this was not a primary research objective, infor-
mation about specific plants surfaced in this study. The
effects of these plants are speculative; the presence of
putative cyclotides in Dantoroa/Denturus requires fur-
ther investigation. In order to truly inform care, more
can be learned about this and other plants used, includ-
ing the active chemical components, dosing specifica-
tions and potential adverse effects [38]. Of particular
interest is Fankamora, the medicinal tea identified by
health practitioners in this study as linked to complications
including rapid contractions, hypertonia, and hemorrhage
from cervical tear. Information about this and other teas
may enable the health provider to sensitize women during
antenatal consultation about concerns of tambavy use dur-
ing labor. It is also possible that these plants could be used
to develop novel drugs including a Malagasy-owned
uterotonic. Further efforts to understand the proper-
ties of uterotonic plants must be ethically grounded,
with the intention of benefitting Malagasy people and
acknowledging the work of Matrones.
Findings of this study also have policy implications, par-
ticularly regarding the debate about the availability of miso-
prostol for reproductive health purposes in Madagascar.
The contention around this issue is related to concerns that
increased access to the drug would lead to more abortions
and cases of uterine rupture. Findings from community-
based misoprostol distribution projects in multiple settings
indicate that the distribution and sensitization at the
village-level is feasible and that women can use the drug
correctly at home births [27–32]. Since the dose and poten-
tial complications related to medicinal plants are issues of
concern, the controlled dose of misoprostol should be the
preferred uterotonic choice where oxytocin is not available.
Registration of generic misoprostol for reproductive health
purposes would increase uterotonic coverage and thus avert
a proportion of avoidable maternal deaths. In addition to
misoprostol registration, creating an enabling environment
where women have access to comprehensive obstetric care
should remain a priority. One drawback of misoprostol is
that when used prophylactically, it cannot then be used as
treatment if the woman bleeds anyway. This is in contrast
to oxytocin, which can be given prophylactically during
active management of the third stage of labor, and then
given again as treatment to the same woman if she happens
to bleed [10]. Policies that aim to increase uterotonic
coverage should be attentive to these considerations.
Despite the illegal status of abortion in Madagascar,
study participants indicated that the practice of unsafe
abortion is commonplace. Given the danger of unsafe
abortion, it is recommended that health practitioners at
CSB posts be trained to provide post-abortion care. Find-
ings from the 2009 study on misoprostol for treatment of
incomplete abortion in Antananarivo indicate the drug’s
potential as first-line treatment for incomplete abortion
particularly in rural and low-resourced areas where pro-
viders may not be trained on standard surgical evacuation
[12]. In addition to ensuring access to post-abortion care,
it is recommended that policies be put into place that
increase access to an array of family planning methods at
the village level. This would help to reduce the unmet
need for family planning (which was 20 % in 2010), thus
averting unintended pregnancies and saving lives [39].
Conclusions
In conclusion, efforts to increase uterotonic coverage in
Madagascar should be aware that the work of Matrones,
including administration of homeopathic remedies, is a
significant aspect of Malagasy culture. Findings of this
study seem to indicate Matrones’ intentions to administer
uterotonics for safer childbirth. This intention, coupled
with health practitioner concern about unsafe dosage and
related complications, and the presence of putative
cyclotides in at least one of the Matrones’ plants, points
to a need for availability of an evidence-based utero-
tonic at the village level. As the public health system
continues to develop, attention should be paid to the
role of Matrones in helping women to access such
evidence-based interventions.
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